Dupilumab Reduces Biomarkers Indicative of Type 2 Inflammation in Children Aged ≥ 6 Months to < 6 YearsWith Moderate-to-Severe Atopic Dermatitis

被引：0
|
作者：
Pinter, Andreas [1 ]
Paller, Amy [2 ,3 ]
Guttman-Yassky, Emma [4 ,5 ]
Boguniewicz, Mark [6 ,7 ]
Sun, Yiping [8 ]
Wolfe, Kelley [9 ]
Dillon, Myles [8 ]
机构：
[1] Univ Hosp Frankfurt Main, Frankfurt, Germany
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Ann & Robert H Lurie Childrens Hosp, Chicago, IL USA
[4] Icahn Sch Med Mt Sinai, Med Ctr, New York, NY USA
[5] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA
[6] Natl Jewish Hlth, Denver, CO USA
[7] Univ Colorado, Sch Med, Denver, CO USA
[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[9] Sanofi, Bridgewater, MA USA
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P155
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [21] Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years
    Paller, Amy S.
    Silverberg, Jonathan I.
    Gonzalez, Mercedes E.
    Schneider, Lynda C.
    Sidbury, Robert
    Chen, Zhen
    Bansal, Ashish
    Wang, Zhixiao
    Prescilla, Randy
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [22] Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
    Paller, Amy S.
    Siegfried, Elaine C.
    Cork, Michael J.
    Arkwright, Peter D.
    Eichenfield, Lawrence F.
    Ramien, Michele
    Khokhar, Faisal A.
    Chen, Zhen
    Zhang, Annie
    Cyr, Sonya L.
    PEDIATRIC DRUGS, 2024, 26 (02) : 163 - 173
  • [23] Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
    Amy S. Paller
    Elaine C. Siegfried
    Michael J. Cork
    Peter D. Arkwright
    Lawrence F. Eichenfield
    Michele Ramien
    Faisal A. Khokhar
    Zhen Chen
    Annie Zhang
    Sonya L. Cyr
    Pediatric Drugs, 2024, 26 : 163 - 173
  • [24] Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate-to-severe AD
    Paller, A.
    Wollenberg, A.
    Simpson, E.
    Beck, L.
    Hong, C-H
    Marcoux, D.
    Chen, Z.
    Levit, N.
    Bansal, A.
    Rossi, A.
    Chao, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 57 - 58
  • [25] 411 Long term laboratory safety of dupilumab in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [26] Long Term Hematologic Laboratory Safety of Dupilumab in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
    Siegfried, Elaine
    Cork, Michael J.
    Lockshin, Benjamin
    Boguniewicz, Mark
    Uppal, Sumeet
    Vass, Maria
    Khokhar, Faisal A.
    Bansal, Ashish
    Sierka, Debra
    Cyr, Sonya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB62 - AB62
  • [27] Dupilumab treatment improves health-related quality of life in children aged 6 months-5 years with moderate-to-severe atopic dermatitis
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Zhang, Haixin
    Wang, Zhixiao
    Rodriguez Marco, Ainara
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E104 - E105
  • [28] P6.09 Hematologic laboratory parameters in adults and children aged 6 months to 18 years with moderate-to-severe atopic dermatitis treated with -dupilumab
    Paller, A. S.
    Siegfried, E. C.
    Zhang, H.
    Khokhar, F. A.
    Homann, A.
    Gonzalez, T.
    ALLERGOLOGIE, 2022, 45 (08) : 624 - 624
  • [29] DUPILUMAB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AGED 6 MONTHS TO 5 YEARS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AND THEIR CAREGIVERS
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Zhang, Haixin
    Wang, Zhixiao
    Marco, Ainara Rodriguez
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 49 - 49
  • [30] Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis
    Siegfried, Elaine C.
    Cork, Michael J.
    Arkwright, Peter D.
    Wollenberg, Andreas
    Eichenfield, Lawrence F.
    Ramien, Michele
    Khokhar, Faisal A.
    Chen, Zhen
    Zhang, Annie
    Cyr, Sonya L.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
12345